Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease

Thrombosis Research

Volumn 87, Issue 6, 1997, Pages 521-526

  Watzke, H H ^a   Schuttrumpf J ^a   Graf, S ^a   Huber, K ^a   Panzer, S ^a  

^a NONE

Author keywords

Coronary heart disease; Genetic polymorphism; Prothrombin

Indexed keywords

DNA; PROTHROMBIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0343035591     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00181-3     Document Type: Article

References (17)

1. CHANDLER AB, CHAPMAN I, ERHARDT LR, et al. Coronary thrombosis in myocardial infarction: report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am J Cardiol1974;34:823-33.
2. FUSTER V, BADIMON L, BADIMON JJ, CHESEBRO JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326:242-50.
3. LAM JYT, CHESEBRO JH, STEELE PM, DEWANJEE MK, BADIMON L, FUSTER V. Deep arterial injury during experimental angioplasty: relation of a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. J Am Coll Cardiol 1986;8:1380-6.
4. Report of the Sixty Plus Reinfarction Study Research Group. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet, 2:989-994, 1981.
5. CHESEBRO JH, FUSTER V Antithrombotic therapy for acute myocardial infarction: Mechanisms and prevention of deep venous thrombosis, left ventricular and coronary artery thromboembolism. Circulation. 74((suppl III):):1986;III-1-III-10.
6. MEADE TW, MELLOW S, BROZOVICH M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:533-7.
7. WILHELMSON L, SVÄRDSUDD K, KORSAN-BENGTSEN K, LARSON B, WELIN L, TIBLIN G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311:501-5.
8. KANNEL WB, WOLF PA, CASTELLI WP, D'AGOSTINO RB. Fibrinogen and the risk of cardiovascular disease: the Framingham Study. JAMA 1987;258:1183-6.
9. HUMPHRIES SE, COOK M, DUBOWITZ M, STIRLING Y, MEADE TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987, 1:1452-55.
10. POORT SR, ROSENDAAL FR, REITSMA PR, BERTINA RM. A common genetic variation in the 3′untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88: 3698-703.
11. COLMAN RW, MARDER VJ, SALZMAN EW, HIRSH J. Overview of Hemostasis. In Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Thrombosis and Hemostasis: Basic Principles and Clinical Practice: Philadelphia, JB Lippincott, 1987.
12. WHITE GC, WORKMAN EF, LUNDBLAD RL: Platelet-thrombin interactions. The platelet as a substrate for thrombin. In Lundblad RL, Fenton JW, Mann KG (eds): The Chemistry and Biology of Thrombin pp 479-498: Ann Arnbor, Ann Arbor Press, 1977.
13. BLIN N, STAFFORD DW. Isolation of high molecular weight DNA. Nucleic Acid Res 1976, 3:2303-08.
14. SAIKI RK, GELFAND DH, STOFFEL S, SCHARF SJ, HUGUCHI R, HORN GT, MULLIS KB, ERLICH HA. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1988, 239:487-91.
15. MITUSCH R, SIEMENS HJ, GARBE M, WAGNER T, SHEIKHZADEH A, DIEDERICH KW. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy.
16. CHEN LB, BUCHANAN JM: Mitogenic activity of of blood components. I.thrombin and prothrombin. Proc Natl Acad sci USA 1975, 72:131.
17. McNAMARA CA, SAREMBOCK IJ, GIMPLE LW, FENTON JW, COUGHLIN SR, OWENS GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. JCI 1993, 91:94-98.